Glasgow, United Kingdom

ESTRO 2024

Local time in host city

Programme

10 Sessions
Monday
May 06
11:40 - 12:40
Armadillo
Ben Slotman, The Netherlands;
Emmanouil Fokas, Germany
The latest clinical trials will be presented during this plenary session. Join us to learn of the latest results and developments in clinical trials.
Proffered Papers
Interdisciplinary
Monday
May 06
11:40 - 12:40
M1
James Good, United Kingdom;
Stefanie Corradini, Germany
Joint Multidisciplinary Tumour Board
Clinical
Monday
May 06
13:10 - 14:10
Forth
Bruno Fionda, Italy;
Morten Horsholt Kristensen, Denmark
This session addresses hypofractionation from the different perspectives of the radiation oncology professionals: the radiation biologist’s, the radiation oncologist’s, the physicist’s, and the RTT’s. It is an informative session, where the background of the audience is taken into account and it covers every aspect of hypofractionation, from the cell to accelerator and everything in between.
Symposium
Young
Monday
May 06
14:15 - 14:40
Armadillo
Award Lecture
Interdisciplinary
Monday
May 06
14:40 - 14:55
Armadillo
Emmanouil Fokas, Germany
Award Lecture
Interdisciplinary
Monday
May 06
15:00 - 16:15
Hall 2
Coen Hurkmans, The Netherlands;
Fiona McDonald, United Kingdom
This will be an important interdisciplinary session dedicated to guidelines and good practice in radiation oncology. We will cover the latest publications, highlighting the work of the guidelines committee & its sub-groups in addition to the authors of the individual guidelines. It will cover numerous aspects of radiation oncology: site specific guidelines (RCC, prostate cancer, GBM), technical guidelines (breath-hold RT), guidelines on radiation toxicity (radiodermatitis) and cross-cutting guidelines (spine SBRT) involving different radiation oncology professionals (physicians, physicists, RTT etc.). Ensure you are up to date in your practice by attending this session.
Symposium
Interdisciplinary
Monday
May 06
15:00 - 16:15
Armadillo
Gaber Plavc, Slovenia;
James Bates, USA
Attendees can anticipate a scientific symposium encompassing critical aspects of head and neck cancer care. Topics will include an examination of how socioeconomic factors impact treatment outcomes, along with discussions on strategies aimed at reducing the observed survival gap. Presentations will also analyze the prevalence of cisplatin ineligibility among elderly patients and the varied care patterns observed globally. Potential treatment intensification strategies, particularly in the context of HPV-negative oropharyngeal cancers, will be explored. Additionally, the session will provide insights into the radiobiological mechanisms contributing to treatment resistance in squamous cell carcinoma, with a focus on identifying potential biomarkers and personalized therapeutic approaches.
Symposium
Clinical
Monday
May 06
15:00 - 16:15
Lomond Auditorium
Panagiotis Balermpas, Switzerland;
Tom Roques, United Kingdom
Joint Symposium
Clinical
Monday
May 06
15:00 - 16:15
Hall 1
Ghizela Ana Maria Salagean, Romania;
Jordi Saez, Spain
Image-Guided Radiotherapy (IGRT) is crucial in modern radiotherapy, but kV imaging requires thorough justification and optimization, following the principles outlined in the Basic Safety Standards Directive (BSSD2013/59). To that aim, problems and challenges must be addressed to maximize the benefits of kV-based IGRT procedures while minimizing associated risks. In this session, these challenges will be described, as well as the modelling of kV and MV IGRT systems. Different strategies for the justification and optimisation of imaging procedures will be presented, including adaptive radiotherapy strategies, and clinical applications will be discussed.
Symposium
Physics
Monday
May 06
15:00 - 16:15
Hall 3
Gert Meijer, The Netherlands;
Pavel Dvorak, Czech Republic
This session will start with an introduction to the concept of dose paining and its development the last 25 years, before methodological challenges and solutions are presented. Illustrations of completed and ongoing dose painting trials will be given. Next, an overview of dose painting using prognostic and longitudinal imaging biomarkers will be presented, focusing on MRI- and PET-based studies, in particular the latest opportunities arising with the integrated MRI-Linac. The session will end with an overview of the technological developments the last 25 years and a prospect of the possibilities these new technologies will open for future personalized radiotherapy using dose painting.
Symposium
Physics
+(event:"415f9a23-87eb-ed11-8849-000d3adea44c")